Dr. Martin Murphy is a Co-Founder and serves as Chief Executive Officer at Syncona. He served as Board Member at Neogene Therapeutics and Cambridge Epigenetix. He serves as the Chairman at Anaveon, Azeria Therapeutics, and Quell Therapeutics. He served as Project Manager at Cambridge Consultants. He serves as a Board Member of Resolution Therapeutics and Achilles Therapeutics. He is the Chairman of Blue Earth Diagnostics.